News and analysis dedicated to the commercial litigation funding sector including regulatory issues, case developments, funding activities, and more.

The average IRS whistleblower claim takes more than eight years to pay out, if they pay out at all. That’s a huge gamble, but one that isn’t stopping one new litigation funder, whose brand new fund is solely devoted to funding IRS whistleblower claims.

New questions have arisen over payouts to top Burford executives, including CEO Christopher Bogart and co-foudner Jonathan Molot. Despite founding the company, the pair were not actually employees of Burford Capital until 2012. Prior to that, they formed an advisory firm – Burford Group Limited – and charged Burford Capital fees for their advisory work. In the wake of the Muddy Waters allegations, the pair are facing questions about the complex financial structure, as well as their current salaries which remain undisclosed, given the fact that neither is on the company’s board. 

In what could be the largest class action in Australian history, Regency Funding is bankrolling a claim against several car makers over faulty airbags which led to at least one fatality and multiple injuries. However one of the car makers, BMW, is challenging the common fund order that allows Regency to collect 25% of any payout, even from those who have not formally joined the class. 

Burford Capital CEO Christopher Bogart and co-founder Jonathan Molot have shot back at US-based hedge fund Muddy Waters’ claims that Burford misreports its earnings, and is ‘arguably insolvent.’ In a call to investors earlier today, Bogart characterized the allegations as ‘false and misleading,’ and sought to assure investors by stating that both he and Molot had personally invested $4MM into Burford’s stock after the Muddy Waters announcement was made. 

There’s been much talk about litigation funding and legal fees, and whether the existence of funding generates an inherent conflict of interest. While there are some legitimate concerns here, the anxiety is mostly overblown. In an increasingly-commoditized industry, litigation funders aren’t likely to risk repetitional harm by directing or even influencing case management and strategy. 

All of that said, legal fees are only one side of the coin. Funders also cover case expenses, and here is an area where conflict of interest may actually arise. 

US-based hedge fund Muddy Waters has caused some serious ripples with its allegations against Burford Capital. In a recently released video, Muddy Waters CEO contends that Burford’s largest shareholder – Invesco – essentially bailed out Napo Pharmaceuticals, a company whose legal claim Burford was financing. 

A new survey by Validity Finance and ALM has yielded some impressive results for litigation funders to harp onto. A full 98% of attorneys surveyed who had used litigation finance at least once in the past said they would do so again, and 93% found their experience to be positive. 

London, 5th August 2019, Augusta, the UK’s largest litigation and dispute funding institution by case volume – today announces the appointment ofAnna Malek as Head of HR, based in London. Anna joins from software and services group Editec where, as Global Head of HR, she managed the full range of people related functions.

As litigation funding gains mainstream acceptance, there have been more and more headline-making allegations which are casting a shadow over the industry. Despite the funding community’s best efforts to assuage such ethical concerns, they persist and continue to plague the nascent market. 

Legal Tech is slowly-but-surely permeating all aspects of the Legal Services industry. And one fast-moving sector of Legal Tech is billing software, which seeks to scrape data on legal costs to better predict how much lawyers will end up charging on a given claim. 

With no automatic enforcement mechanism in place and only 60% of awards under £10,000 being fully enforced, the UK is experiencing a crisis of enforcement. Given that litigation funders must take collection risk into account when proposing an investment thesis, it’s worth examining the current enforcement climate in the UK in greater detail.

Last year, the New York City Bar Association issued an advisory opinion suggesting that funding agreements between lawyers and third party funders violates ABA Model Rule 5.4(a), which prohibits fee sharing with non-lawyers. The opinion has sparked furious debate (and much consternation) in the litigation funding community ever since. But practically speaking, how has the NYC Bar’s opinion impacted law firm funding? 

Recently, law firm Kirkland & Ellis announced a ten-fold increase in investment dollars towards contingency-fee plaintiff-side claims. Alternative fee arrangements have been the most profitable component of the law firm thus far, so management figures ‘why not roll the dice’ on what’s already been working? The question now is: is Kirkland’s approach a harbinger of things to come? And if so, how will this impact litigation funders down the road? 

Dividex, the international securities class action broker and case manager, wanted in on a Novo Nordisk class action after the stock shed over $50B in the wake of fraud allegations. The only problem? No litigation funders would bite, given that the Danish Pharma company would have to face the scales of justice on its home turf (international securities actions can no longer be tried in the U.S., pursuant to a 2010 Supreme Court decision). And since funding is needed to get an international securities action off the ground, the deal was dead in the water. Until, that is, Dividex packaged the deal into its own version of a portfolio funding arrangement. 

GoFundMe recently cancelled an Australian rugby player’s crowdfunded legal campaign, and the story made international headlines. Now some experts are scrutinizing the ethical and practical concerns of crowdfunding litigation; some of which will sound very familiar to litigation funders, yet others are unique to the crowdfunding niche.